TNSN91117A1 - SOLID PRESENTATIONS OF THE ALMOKALANT AND PROCESSES FOR THEIR MANUFACTURE - Google Patents

SOLID PRESENTATIONS OF THE ALMOKALANT AND PROCESSES FOR THEIR MANUFACTURE

Info

Publication number
TNSN91117A1
TNSN91117A1 TNTNSN91117A TNSN91117A TNSN91117A1 TN SN91117 A1 TNSN91117 A1 TN SN91117A1 TN TNSN91117 A TNTNSN91117 A TN TNSN91117A TN SN91117 A TNSN91117 A TN SN91117A TN SN91117 A1 TNSN91117 A1 TN SN91117A1
Authority
TN
Tunisia
Prior art keywords
almokalant
manufacture
processes
solid presentations
solid
Prior art date
Application number
TNTNSN91117A
Other languages
French (fr)
Inventor
Hjalmar Andersson Kjell
Johan Gunnar Lundberg Per
Roger Simonsson Leif
Helevna Johansson Wingstrand Karin
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN91117A1 publication Critical patent/TNSN91117A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Treatment Of Metals (AREA)

Abstract

PRESENTATIONS PHARMACEUTIQUES SOLIDES CONTENANT UN COMPLEXE D'ALMOKALANT, ET DES PROCEDES EN VUE DE LEUR FABRICATIONSOLID PHARMACEUTICAL PRESENTATIONS CONTAINING AN ALMOKALANT COMPLEX, AND METHODS FOR THEIR MANUFACTURE

TNTNSN91117A 1990-12-07 1991-12-06 SOLID PRESENTATIONS OF THE ALMOKALANT AND PROCESSES FOR THEIR MANUFACTURE TNSN91117A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9003902A SE9003902D0 (en) 1990-12-07 1990-12-07 SOLID DOSAGE FORMS OF A DRUG

Publications (1)

Publication Number Publication Date
TNSN91117A1 true TNSN91117A1 (en) 1992-10-25

Family

ID=20381121

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN91117A TNSN91117A1 (en) 1990-12-07 1991-12-06 SOLID PRESENTATIONS OF THE ALMOKALANT AND PROCESSES FOR THEIR MANUFACTURE

Country Status (26)

Country Link
EP (1) EP0560821A1 (en)
JP (1) JPH06503312A (en)
CN (1) CN1063039A (en)
AP (1) AP258A (en)
AU (1) AU8930791A (en)
BG (1) BG97851A (en)
CA (1) CA2097178A1 (en)
CZ (1) CZ103793A3 (en)
FI (1) FI932554A (en)
HU (1) HUT64217A (en)
IE (1) IE914137A1 (en)
IL (1) IL100150A0 (en)
IS (1) IS3788A7 (en)
LT (1) LTIP1717A (en)
MA (1) MA22355A1 (en)
MX (1) MX9102325A (en)
MY (1) MY106776A (en)
NZ (1) NZ240731A (en)
PT (1) PT99719A (en)
SE (1) SE9003902D0 (en)
SK (1) SK55693A3 (en)
TN (1) TNSN91117A1 (en)
TW (1) TW215057B (en)
WO (1) WO1992010172A1 (en)
YU (1) YU186891A (en)
ZA (1) ZA919264B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19602757A1 (en) * 1996-01-26 1997-07-31 Boehringer Mannheim Gmbh Solid instant release dosage forms and processes for their manufacture
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
JP4504467B2 (en) * 1998-07-30 2010-07-14 佐藤製薬株式会社 Orally disintegrating tablets
JP7426685B2 (en) * 2018-06-14 2024-02-02 株式会社東洋新薬 tablet

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8705150D0 (en) * 1987-12-23 1987-12-23 Haessle Ab NOVEL ANTIARRHYTHMIC AGENTS
IL90245A (en) * 1988-05-11 1994-04-12 Glaxo Group Ltd Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
SE8902236D0 (en) * 1989-06-20 1989-06-20 Haessle Ab NOVEL POLYSTYRENESULPHONATE

Also Published As

Publication number Publication date
CZ103793A3 (en) 1994-02-16
ZA919264B (en) 1992-08-26
IE914137A1 (en) 1992-06-17
LTIP1717A (en) 1995-07-25
CN1063039A (en) 1992-07-29
NZ240731A (en) 1993-10-26
IL100150A0 (en) 1992-08-18
BG97851A (en) 1994-04-29
MX9102325A (en) 1992-06-01
CA2097178A1 (en) 1992-06-08
WO1992010172A1 (en) 1992-06-25
MA22355A1 (en) 1992-07-01
AP9100338A0 (en) 1992-01-31
MY106776A (en) 1995-07-31
SE9003902D0 (en) 1990-12-07
AU8930791A (en) 1992-07-08
SK55693A3 (en) 1993-10-06
YU186891A (en) 1994-04-05
FI932554A0 (en) 1993-06-04
EP0560821A1 (en) 1993-09-22
JPH06503312A (en) 1994-04-14
AP258A (en) 1993-06-03
HUT64217A (en) 1993-12-28
FI932554A (en) 1993-06-08
HU9301670D0 (en) 1993-09-28
PT99719A (en) 1992-10-30
TW215057B (en) 1993-10-21
IS3788A7 (en) 1992-06-08

Similar Documents

Publication Publication Date Title
DK588487A (en) IMPROVED METAL CONTAINING PHARMACEUTICAL AGENTS
CY2123B1 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides drugs containing these compounds and use of such drugs
MX9704030A (en) 2-heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof.
BE896027A (en) NOVEL GLYCOPROTEINS, PRODUCTION METHODS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF TUMORS CONTAINING THE SAME
NO972391L (en) 2-Substituted 1,2,5-thiadiazolidin-3-one 1,1-dioxides and their preparations and methods
DE69014351T2 (en) Pyridinecarboxamide derivatives and pharmaceutical compositions containing them.
IT7822397A0 (en) PROCEDURE AND SYSTEM FOR THE INCINERATION OF HOUSEHOLD WASTE.
BE878806A (en) PHOTOGRAPHIC WHITENING COMPOSITION AND PHOTOGRAPHIC PROCESSING METHOD USING THE SAME
TR199800717T2 (en) To prepare medication for the treatment of amyotrophic lateral sclerosis
ATE182271T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES
FR2368958A1 (en) SUBSTANCES ISOLATED FROM GONADERMA LUCIDUM (FR.) KARST AND THEIR APPLICATION IN THERAPEUTICS
TNSN91117A1 (en) SOLID PRESENTATIONS OF THE ALMOKALANT AND PROCESSES FOR THEIR MANUFACTURE
DE69420229D1 (en) Pharmaceutical composition for the treatment of AIDS
NO972449L (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one-1,1-dioxide derivatives and preparations and process for use thereof
NL7811027A (en) PROCESS FOR THE MANUFACTURE OF HIGHLY PURE SEMI-CONDUCTOR MATERIALS AND METALS.
FR2550944B1 (en) PHARMACEUTICAL ASSOCIATION BASED ON TUMOR ANTI-CELL ANTIBODIES AND CYTOTOXIC CONJUGATES, SUITABLE IN PARTICULAR FOR THE TREATMENT OF CANCERS
BE829859A (en) PHARMACEUTICAL METHODS AND COMPOSITIONS FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
BE888525A (en) NUCLEOSIDE OF THE DESAZAPURINS CLASS, COMPOSITIONS CONTAINING THEM AND THEIR APPLICATION IN MEDICINE,
FI844645L (en) 1,7-DIPHENYL-3-METHYLAZA-7-CYAN-8-METHYL-NONAN FOR ANALYSIS OF THE CONSTRUCTION OF SJUKDOMAR.
FR2658810B1 (en) COMPOSITION CONTAINING TRACE ELEMENTS AND METHODS USING THE SAME.
FR2352891A1 (en) DENTAL ALLOY POWDER CONTAINING INDIUM
FR2664814B1 (en) SOLID PHARMACEUTICAL COMPOSITIONS AND THEIR PREPARATION PROCESS.
BE863802A (en) NEW DERIVATIVES OF EVERNINOMICINE, THEIR METHODS OF PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAID DERIVATIVES
FR2344545A1 (en) (2-PYRIMIDINYLTHIO) -ALKANOIC ACID AMIDES HAVING ANTILIPEMIC ACTIVITY, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AU645507B2 (en) 1,4,10,13-tetraoxa-7,16-diazacyclooctadecane derivatives, pharmaceutical compositions containing them and their use for the removal of toxic metal ions and radioactive isotopes from the living organism